Unichem Laboratories Limited (UNICHEMLAB.NS)
- Previous Close
573.05 - Open
575.50 - Bid 571.75 x --
- Ask 571.70 x --
- Day's Range
568.20 - 576.15 - 52 Week Range
501.00 - 937.95 - Volume
3,228 - Avg. Volume
52,036 - Market Cap (intraday)
40.426B - Beta (5Y Monthly) 0.26
- PE Ratio (TTM)
-- - EPS (TTM)
-4.12 - Earnings Date May 22, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Aug 2, 2022
- 1y Target Est
--
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, bulk drugs, and chemicals. Unichem Laboratories Limited was founded in 1944 and is based in Mumbai, India.
www.unichemlabs.com2,875
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: UNICHEMLAB.NS
View MorePerformance Overview: UNICHEMLAB.NS
Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: UNICHEMLAB.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: UNICHEMLAB.NS
View MoreValuation Measures
Market Cap
40.54B
Enterprise Value
41.56B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.18
Price/Book (mrq)
1.68
Enterprise Value/Revenue
2.24
Enterprise Value/EBITDA
33.99
Financial Highlights
Profitability and Income Statement
Profit Margin
-1.52%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
19.03B
Net Income Avi to Common (ttm)
-289.04M
Diluted EPS (ttm)
-4.12
Balance Sheet and Cash Flow
Total Cash (mrq)
1.98B
Total Debt/Equity (mrq)
12.50%
Levered Free Cash Flow (ttm)
--